Stage III Verrucous Carcinoma of the Larynx Withdrawn Phase 1 Trials for DB12117 (Mitometh)

IndicationStatusPhase
DBCOND0029516 (Stage III Verrucous Carcinoma of the Larynx)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01728480Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyTreatment